Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pets at Home sees pre-tax profits fall by nearly 40 per cent
The firm said it is ‘confident’ about the year ahead and expects to see revenue growth ahead of both the retail and vet markets.
Full year performance ‘ahead of expectations’, statement says

Pets at Home has seen its statutory pre-tax profits fall by 37.7 per cent, to £49.6 million in the 12 months up to the end of March.

However, the group said its full year performance was ‘ahead of expectations’. The retail business is ‘growing strongly’ with like for like sales growth of 5.1 per cent, to £854.6 million. It also reported an 8.3 per cent rise in shares.

Last year the firm announced plans to buy out up to 55 practices from joint venture partners, of which up to 30 could close. In its latest report the group said the veterinary arm of the business is ‘performing well’ and the restructuring plans are on track to complete later this year.

By 17 May 2019, 48 buy outs had been completed, of which 19 have closed.

The firm said it is ‘confident’ about the year ahead and expects to see revenue growth ahead of both the retail and vet markets.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."